Continuous Flow Chemistry Landscape — PatSnap Eureka
Continuous Flow Chemistry: Patent Intelligence for R&D Teams
From Ruhrchemie's 1955 tubular oxo synthesis to AI-native platforms filing in 2025–2026, continuous flow chemistry is undergoing a fundamental shift. This landscape maps reactor architectures, closed-loop control systems, and autonomous optimization across pharma, bioprocessing, semiconductor, and industrial chemistry sectors.
Three Intersecting Domains Define the Flow Chemistry Landscape
Continuous flow chemistry — the practice of conducting chemical reactions in continuously flowing streams through reactor channels, tubes, or microreactors rather than conventional batch vessels — is gaining strategic importance as the pharmaceutical, specialty chemical, and semiconductor industries seek greater process control, safety, and scalability.
Within this dataset, continuous flow chemistry manifests across three intersecting technical domains: (1) physical reactor architecture enabling continuous-stream reactions; (2) automation, sensing, and closed-loop control systems that govern flow processes; and (3) AI/machine learning layers that optimize reaction conditions, predict outcomes, and manage catalyst lifecycles.
The foundational mechanism — passing reactants through a confined, continuous-flow reaction space under controlled temperature and pressure — is represented as early as 1955 in Ruhrchemie Aktiengesellschaft's tubular oxo synthesis process, which employed 150–400 metre-long coiled reaction tubes (4–50 mm diameter) immersed in heat-transfer baths to achieve continuous hydroformylation at pressures exceeding 50 kg/cm². Modern implementations extend this principle to microstructured flow reactors, modular fluidic platforms, and AI-supervised continuous bioprocessing trains.
A modular system architecture for multi-step flow reactions is explicitly disclosed by SRI International, covering a substrate layer with reconfigurable reactor and separator modules, integrated analytical devices, and feedback-based process controllers. Peptilogics, Inc. separately discloses an AI-enabled automated flow synthesis platform for peptide sequences that couples real-time spectral sensing with machine-learning-driven recipe optimization during the flow process itself. Regulatory bodies such as the FDA have issued continuous manufacturing guidance that is accelerating pharma adoption.
Four Innovation Clusters Shaping Continuous Flow Chemistry
Patent filings in this dataset group into four distinct technical clusters, from foundational hardware to autonomous AI-driven reaction optimization.
Tubular and Microstructured Flow Reactors
This foundational cluster covers the physical hardware of continuous flow: tubes, coils, microchannels, and structured reactor geometries that impose defined residence times and heat/mass transfer profiles. Ruhrchemie's 1955 oxo synthesis specified tubular coils immersed in water baths to sustain continuous high-pressure hydroformylation. WuXi AppTec's 2024 platform describes a fully standardized system with inlet/outlet modules, transport modules, and reaction modules connected by pipework for pharmaceutical continuous synthesis. Cellular Process Chemistry's 2009 parallel system specified that each reactor in an array maintains identical fluid properties to the test reactor, enabling direct scale-up without re-optimization.
Key assignees: Ruhrchemie, WuXi AppTec, Cellular Process ChemistryModular and Reconfigurable Flow Platforms
This cluster focuses on plug-and-play system architectures where reactor modules, separator modules, and analytical modules are interchangeably mounted on a common substrate or backbone, enabling the same hardware to support discovery, optimization, and production workflows. SRI International's modular multi-step chemical reaction system discloses a substrate layer with flow connectors collaborating with selectable processing modules and regulator modules, all monitored by in-line analytical devices feeding back to a processing circuit. Gelest Technologies extends modularity to the semiconductor domain: a precursor synthesis chamber directly coupled to a thin film processing chamber, with a controller synchronizing synthesis rate to consumption rate in real time.
Key assignees: SRI International, Gelest TechnologiesReal-Time Sensing and Closed-Loop Process Control
This cluster covers in-line or on-line sensors coupled to feedback controllers that continuously monitor reaction properties and adjust operating parameters without human intervention. The Administrators of the Tulane Educational Fund holds a family of patents covering apparatus that automatically and continuously extracts chemical species from a reactor, passes them through detectors to generate a continuous data stream, fits those data to a mathematical function to predict future property values, and uses those predictions to make real-time process decisions. Peptilogics extends this by coupling real-time spectral data from a flow reaction chamber to a machine-learning engine that identifies reaction characteristics at specific flow points and optimizes synthesizing recipes accordingly.
Key assignees: Tulane Educational Fund, PeptilogicsAutonomous and AI-Driven Reaction Optimization
This cluster covers methods where algorithms — genetic algorithms, machine learning models, or reinforcement approaches — autonomously select, execute, and iterate reaction conditions within continuous or flow-compatible platforms to explore chemical space or optimize yield. The University Court of the University of Glasgow discloses a 2018 evolutionary synthesis method using genetic algorithms to select successive chemical input combinations for a reaction space, and a 2023 autonomous exploration method for synthesizing chemical libraries through multigenerational synthetic stages where product fitness functions guide input selection. Merck Patent GmbH discloses a system that assembles test kits from representative chemical groups, performs experiments, generates distance matrices, and ranks predictive chemicals by score.
Key assignees: Univ. of Glasgow, Merck Patent GmbHFiling Activity, Assignees, and Jurisdictions at a Glance
Visualisations derived entirely from patent records retrieved in this dataset. All values reflect filing counts and distributions within the retrieved record set.
Top Assignees by Filing Activity
BASF SE leads with at least 5 distinct filings; Tulane Educational Fund holds at least 4 in a concentrated family covering real-time property prediction.
Filing Distribution by Jurisdiction
KR (South Korea) is the most-represented jurisdiction; JP (Japan) is second; CN, US, and WO follow in this dataset.
Innovation Maturity Timeline by Filing Era
Publication dates in this dataset span from 1955 to early 2026, indicating a multi-generational technology field at an advanced but still-active development stage.
Where Continuous Flow Chemistry Is Being Deployed
Four distinct application sectors emerge from this dataset, each with different assignee profiles, regulatory drivers, and technology maturity levels.
| Sector | Key Assignees | Technology Focus | Filing Jurisdiction | Notable Feature |
|---|---|---|---|---|
| Pharmaceutical | WuXi AppTec, Peptilogics, Beijing Shanwei | Standardized automated flow synthesis; AI-enabled peptide manufacturing; PET radiopharmaceutical modular synthesis trains | CN, US | WuXi AppTec's 2024 platform explicitly emphasizes compliance data traceability and industrial scale-up suitability |
| Biopharmaceutical | Engine Biosciences, Bayer Healthcare | SCADA/PLC/DCS-governed continuous therapeutic protein production; hierarchical ML for biopharmaceutical purification | KR | Engine Biosciences' 2021 system covers laboratory scale to mass production with automated UPLC/HPLC online testing |
| Semiconductor | Gelest Technologies, Gelest Inc. | Integrated on-demand precursor synthesis directly coupled to thin film processing chamber; synchronized synthesis and consumption rates | TW, JP | Controller synchronizes synthesis rate to consumption rate in real time, eliminating intermediate storage |
| Industrial / Petrochemical | BASF SE, Ruhrchemie, Cellular Process Chemistry | Continuous catalytic reactor management; plant operating condition optimization; parallel-reactor scale-up architectures | JP, KR, GB | BASF SE holds at least 5 filings covering catalyst lifecycle management and hybrid model-based monitoring |
Conduct sector-specific FTO analysis with PatSnap Eureka
Filter by application domain, assignee, and claim type to identify freedom-to-operate risks.
A Distributed Innovation Ecosystem Across Multiple Sectors
Among retrieved results directly relevant to continuous flow chemistry technology, innovation is moderately concentrated: BASF SE and Tulane Educational Fund together account for roughly half of the directly relevant records, but the presence of academic (Glasgow), startup (Peptilogics), and contract research organization (WuXi AppTec) assignees signals a distributed innovation ecosystem across multiple sectors.
KR (South Korea) is the most-represented jurisdiction in this dataset, with a large share of filings from both domestic assignees and international companies filing into South Korea — including BASF SE, Engine Biosciences, Tulane Educational Fund, and Merck Patent GmbH. JP (Japan) is the second most represented, dominated by BASF SE and Gelest filings. The European Patent Office and national offices in these jurisdictions reflect the global spread of continuous flow chemistry IP strategy.
CN (China) features WuXi AppTec and SRI International filings, reflecting manufacturing-scale continuous chemistry activity. US filings are present primarily for Peptilogics' peptide flow synthesis platform. WO (PCT) appears for the University of Glasgow's autonomous library synthesis, signaling broad geographic protection intent. The WIPO PCT system is increasingly used by academic inventors seeking global coverage from a single filing.
IP strategists should assess freedom-to-operate around modular substrate-layer and flow-connector claims — especially SRI International's CN patent family — as these form the backbone of reconfigurable flow platform architectures. For broader IP analytics across continuous chemistry sectors, PatSnap's platform provides landscape and FTO tools.
Five Directions Gaining Momentum in 2022–2026 Filings
Based on filings from 2022–2026 in this dataset, these directions represent the leading edge of continuous flow chemistry innovation.
AI-Native Flow Synthesis Platforms
Peptilogics' 2022–2023 US filings and Merck Patent GmbH's 2025 KR/CN filings point toward flow systems where machine learning is no longer a downstream analysis tool but an embedded real-time decision engine. The University of Glasgow's 2023 autonomous exploration method (WO/CA) extends this to multigenerational autonomous chemical library synthesis.
Standardized Modular Pharmaceutical Flow Platforms
WuXi AppTec's 2024 CN filing for a standardized, modular, automated flow chemistry synthesis platform represents a push toward industry-standard, audit-ready flow hardware in pharmaceutical contract research and manufacturing, emphasizing data completeness, traceability, and industrial scale-up compatibility.
What This Landscape Means for R&D and IP Teams
Five strategic signals derived entirely from the patent dataset — for R&D directors, IP counsel, and innovation strategists in flow chemistry-adjacent sectors.
AI Integration Is No Longer Optional for Competitive Flow Platforms
Multiple recent filings from Peptilogics, Merck Patent GmbH, and the University of Glasgow converge on embedding ML directly into the reaction loop. R&D teams designing flow chemistry platforms without AI-native sensing and recipe optimization will face competitive disadvantage within the 2025–2028 product cycle.
Peptilogics · Merck GmbH · Glasgow 2023Modular, Reconfigurable Architectures Are Becoming the Dominant Commercial Form Factor
SRI International's substrate-and-module system and WuXi AppTec's standardized pharmaceutical platform both emphasize hardware reconfigurability. IP strategists should assess freedom-to-operate around modular substrate-layer and flow-connector claims, especially SRI International's CN patent family.
SRI International CN · WuXi AppTec 2024Pharma and Biopharma Represent the Highest Near-Term Commercial Pull
In this dataset, continuous flow filings from WuXi AppTec, Peptilogics, Engine Biosciences, and Bayer Healthcare cluster heavily in pharmaceutical-grade continuous synthesis and biopharmaceutical purification — sectors with regulatory incentives and cost-of-goods pressures driving adoption. The NIH and regulatory bodies have highlighted continuous manufacturing as a priority for drug supply resilience.
WuXi · Peptilogics · Engine Biosciences · BayerBASF SE's Broad Portfolio Creates a Significant Defensive Perimeter in Industrial Continuous Chemistry
With at least five filings in JP and KR covering data-driven catalyst aging models and operating condition optimization, BASF's IP position in continuous catalytic reactor management is the strongest in this dataset. Entrants in continuous petrochemical or commodity chemical production should conduct detailed FTO analysis against this portfolio. See PatSnap customer case studies for FTO workflow examples.
BASF SE — 5+ JP/KR filingsContinuous Flow Chemistry — key questions answered
Continuous flow chemistry is the practice of conducting chemical reactions in continuously flowing streams through reactor channels, tubes, or microreactors rather than conventional batch vessels, gaining strategic importance as the pharmaceutical, specialty chemical, and semiconductor industries seek greater process control, safety, and scalability.
BASF SE is the most prolific assignee, with at least 5 distinct filings covering chemical plant operating condition determination, catalyst lifecycle management, hybrid model-based monitoring, and chemical manufacturing control — predominantly filed in JP and KR jurisdictions. The Administrators of the Tulane Educational Fund holds a concentrated family of at least 4 filings covering real-time continuous extraction and property prediction systems.
KR (South Korea) is the most-represented jurisdiction in this dataset, with a large share of filings from both domestic assignees and international companies filing into South Korea. JP (Japan) is the second most represented, dominated by BASF SE and Gelest filings. CN (China) features WuXi AppTec and SRI International filings, reflecting manufacturing-scale continuous chemistry activity.
Multiple recent filings from Peptilogics, Merck Patent GmbH, and the University of Glasgow converge on embedding ML directly into the reaction loop. Peptilogics' AI-enabled automated flow synthesis platform couples real-time spectral data from a flow reaction chamber to a machine-learning engine that identifies reaction characteristics at specific flow points and optimizes synthesizing recipes accordingly.
Based on filings from 2022–2026, the following directions are gaining momentum: AI-native flow synthesis platforms; standardized modular pharmaceutical flow platforms; integrated on-demand synthesis and consumption coupling; continuous bioprocessing with digital supervisory control; and blockchain-secured recipe distribution for automated synthesis.
BASF SE's broad catalyst-lifecycle and plant-monitoring IP portfolio creates a significant defensive perimeter in industrial continuous chemistry. With at least five filings in JP and KR covering data-driven catalyst aging models and operating condition optimization, BASF's IP position in continuous catalytic reactor management is the strongest in this dataset. Entrants in continuous petrochemical or commodity chemical production should conduct detailed FTO analysis against this portfolio.
Still have questions? Let PatSnap Eureka answer them for you.
Ask Eureka About Flow Chemistry PatentsAccelerate Your Continuous Flow Chemistry R&D with AI-Powered Patent Intelligence
Join 18,000+ innovators already using PatSnap Eureka to accelerate their R&D. Search across the full continuous flow chemistry patent landscape — by assignee, cluster, jurisdiction, and filing date.
References
- Process for continuously operating the oxo synthesis — Ruhrchemie Aktiengesellschaft, 1955, GB
- Flow chemistry automated synthesis reaction platform — WuXi AppTec (Shanghai Drug Development Co., Ltd.), 2024, CN
- Scalable continuous production system — Cellular Process Chemistry, Inc., 2009, JP
- Modular system for performing multi-step chemical reactions and method of use thereof — SRI International, 2022, CN
- Methods and system for the integrated synthesis, delivery, and processing of source chemicals for thin film manufacturing — Gelest Technologies, Inc., 2019, TW
- Method and system for integrated synthesis, delivery and processing of chemical sources for thin film manufacturing — Gelest, Inc., 2025, JP
- Systems and methods for predicting and controlling the properties of a chemical species during a time-dependent process — Tulane Educational Fund, 2020, KR
- Systems and methods for predicting and controlling chemical species properties during time-dependent processes — Tulane Educational Fund, 2020, JP
- Methods and apparatuses for a unified artificial intelligence platform to synthesize diverse sets of peptides and peptidomimetics — Peptilogics, Inc., 2022, US
- Methods and apparatuses for a unified artificial intelligence platform to synthesize diverse sets of peptides and peptidomimetics — Peptilogics, Inc., 2023, US
- Methods of evolutionary synthesis, including embodied chemical synthesis — Univ. of Glasgow, 2018, JP
- Autonomous exploration for the synthesis of chemical libraries — Univ. of Glasgow, 2023, WO
- Systems and methods for optimizing chemical reactions using machine learning — Merck Patent GmbH, 2025, KR
- Automated integrated continuous systems and bioprocesses for therapeutic protein production — Engine Biosciences Limited, 2021, KR
- Advanced data-driven modeling for purification processes in biopharmaceutical manufacturing — Bayer Healthcare LLC, 2024, KR
- Compact modular multifunctional automated 11C-labeled PET drug synthesizer — Beijing Shanwei Positron Pharmaceutical Technology Co., Ltd., 2014, CN
- System, method and computer program product for determining operating conditions in a chemical production plant — BASF SE, 2022, JP
- System, method and computer program product for determining operating conditions in a chemical production plant — BASF SE, 2025, JP
- Method for monitoring and/or controlling a chemical plant using a hybrid model — BASF SE, 2024, JP
- Method and device for automation of chemical synthesis — Chatterjee, Sourav, 2025, WO
- World Intellectual Property Organization (WIPO) — PCT filing system and global patent data
- European Patent Office (EPO) — patent search and European filing data
- U.S. Food and Drug Administration (FDA) — continuous manufacturing guidance for pharmaceutical production
- National Institutes of Health (NIH) — drug supply resilience and continuous manufacturing research
All data and statistics on this page are sourced from the references above and from PatSnap's proprietary innovation intelligence platform. This landscape is derived from a limited set of patent and literature records retrieved across targeted searches and represents a snapshot of innovation signals within this dataset only.
PatSnap Eureka searches patents and research to answer instantly.